Consensus Valerio Therapeutics Deutsche Boerse AG

Equities

Delayed Deutsche Boerse AG Other stock markets 01:19:53 05/07/2024 am IST			5-day change	1st Jan Change
0.104 ^EUR	+2.97%		+2.97%	-31.35%

22/05	Valerio Therapeutics S.A. Provides Clinical Development Update on Its Phase 1/2 VIO-01 Clinical Trial	CI
30/04	Valerio Therapeutics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI

6bc.QmQL-XjML6SSr8EVICnxJNhcfHT0QxeLnA3kgtdnrtw.BhJZgCqYXuKg5YNQGEOAcI4DMyWlAEfcq1mDu5k_nuQENTyMT6Fw7_Dapg~573b5ff36f6a211e13d9702ed12b62ad

Onxeo : Bryan Garnier & Co initiates the coverage of Onxeo with a “Buy” recommendation	29/20/29	PU
Bryan Garnier & Co Initiates Coverage of Onxeo with a “Buy” Recommendation	27/20/27	GL
Onxeo : Bryan Garnier & Co Initiates the Coverage of Onxeo with a “Buy” Recommendation	27/20/27	BU

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.105 EUR

Average target price

1.2 EUR

Spread / Average Target

+1,042.86%

High Price Target

1.2 EUR

Spread / Highest target

+1,042.86%

Low Price Target

1.2 EUR

Spread / Lowest Target

+1,042.86%